The role of transforming growth factor beta in glioma progression.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (167)
The retinoblastoma protein and cell cycle control
1995 • 4,873 citations
Participation of p53 protein in the cellular response to DNA damage.
1991 • 3,818 citations
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
1993 • 3,680 citations
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
1992 • 3,110 citations
A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
1994 • 2,821 citations
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
1994 • 2,154 citations
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
1994 • 2,071 citations
Mammalian G1 cyclins
1993 • 1,990 citations
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
1994 • 1,970 citations
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
1994 • 1,932 citations
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
1994 • 1,669 citations
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.
1983 • 1,613 citations
TGFβ signals through a heteromeric protein kinase receptor complex
1992 • 1,519 citations
p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
1994 • 1,475 citations
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
1993 • 1,047 citations
Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells
1987 • 998 citations
TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights
1990 • 992 citations
New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues.
1981 • 925 citations
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
1995 • 894 citations
Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation
1990 • 812 citations
Growth Inhibitor from BSC-1 Cells Closely Related to Platelet Type β Transforming Growth Factor
1984 • 779 citations
Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptor
1993 • 779 citations
TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop
1990 • 756 citations
Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin.
1990 • 740 citations
Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation
1985 • 738 citations
Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
1994 • 731 citations
Human D-type cyclin
1991 • 712 citations
Clonal expansion of p53 mutant cells is associated with brain tumour progression
1992 • 687 citations
TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains
1990 • 612 citations
Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
1996 • 585 citations
Negative Regulation of G1 in Mammalian Cells: Inhibition of Cyclin E-Dependent Kinase by TGF-β
1993 • 578 citations
Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.
1993 • 565 citations
Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm3-transfected melanoma cells
1991 • 548 citations
TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest
1993 • 544 citations
Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity.
1986 • 541 citations
Clonal genomic alterations in glioma malignancy stages.
1988 • 520 citations
Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.
1993 • 514 citations
Transforming growth factor production by chemically transformed cells.
1981 • 506 citations
Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation
1992 • 486 citations
How many mutations are required for tumorigenesis? implications from human cancer data
1993 • 466 citations
CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.
1994 • 439 citations
The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis
1994 • 428 citations
Deletion of p16 and p15 genes in brain tumors.
1994 • 416 citations
A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.
1990 • 409 citations
Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.
1990 • 398 citations
Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.
1989 • 391 citations
Absence of WAF1 mutations in a variety of human malignancies
1994 • 390 citations
Inactivation of the Type II Receptor Reveals Two Receptor Pathways for the Diverse TGF-β Activities
1993 • 388 citations
Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family.
1987 • 387 citations
Inhibition of Ras-Induced Proliferation and Cellular Transformation by p16 INK4
1995 • 382 citations
Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
1994 • 377 citations
Transforming growth factor beta and cell cycle regulation.
1995 • 368 citations
T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta.
1987 • 337 citations
A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells.
1994 • 332 citations
Absence of TGF-β Receptors and Growth Inhibitory Responses in Retinoblastoma Cells
1988 • 331 citations
Analysis of the p53 gene and its expression in human glioblastoma cells.
1994 • 329 citations
Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
1995 • 327 citations
Absence of p16(INK4) protein is restricted to the subset of lung cancer lines that retains wildtype RB
1995 • 314 citations
Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors
1994 • 304 citations
Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.
1994 • 290 citations
Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases.
1993 • 276 citations
Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II
1991 • 252 citations
p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
1992 • 248 citations
Alterations of the TP53 gene in human gliomas.
1994 • 246 citations
Potential Role of WAF1/Cip1/p21 as a Mediator of TGF-β Cytoinhibitory Effect
1995 • 244 citations
Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer.
1992 • 237 citations
Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis.
1996 • 232 citations
Activation of p21ras by transforming growth factor beta in epithelial cells.
1992 • 223 citations
The retinoblastoma gene is involved in malignant progression of astrocytomas
1994 • 220 citations
Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation.
1989 • 213 citations
Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis.
1995 • 207 citations
Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest.
1991 • 203 citations
Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas.
1992 • 202 citations
Type beta transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval.
1985 • 191 citations
Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts.
1992 • 181 citations
Receptors for Transforming Growth Factor-β
1993 • 181 citations
High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer.
1995 • 179 citations
Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
1990 • 175 citations
Transforming growth factor β stimulates mamary adenocarcinoma cell invasion and metastasis potential
1990 • 164 citations
Allelotype of human malignant astrocytoma.
1990 • 163 citations
Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1.
1992 • 155 citations
TGF‐β stimulates primary human skin fibroblast DNA synthesis via an autocrine production of PDGF‐related peptides
1989 • 154 citations
Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor β1
1994 • 150 citations
The effect of transforming growth factor-β2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma
1993 • 142 citations
Growth Factor Synthesis and Human Breast Cancer Progression
1995 • 140 citations
Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations
1986 • 139 citations
Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice.
1993 • 138 citations
Differential regulation of expression of two platelet-derived growth factor receptor subunits by transforming growth factor-β
1989 • 136 citations
p53-mediated apoptosis in HeLa cells can be overcome by excess pRB.
1995 • 136 citations
Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells.
1995 • 134 citations
Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-β1 involves activation of protein kinase C
1995 • 133 citations
The glioblastoma‐derived T‐cell suppressor factor/transforming growth factor beta2 inhibits the generation of lymphokineactivated killer (LAK) cells
1988 • 131 citations
Enhanced expression of transforming growth factor‐β and its type‐I and type‐II receptors in human glioblastoma
1995 • 127 citations
Agents that increase cAMP accumulation block endothelial c-sis induction by thrombin and transforming growth factor-beta.
1987 • 126 citations
Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition.
1995 • 124 citations
A Correlative Study of p53 Protein Alteration and p53 Gene Mutation in Glioblastoma Multiforme
1993 • 119 citations
Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells.
1987 • 116 citations
Increased transforming growth factor beta expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells.
1993 • 113 citations
Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts.
1988 • 113 citations
Transforming growth factor‐βs inhibit mitogen‐stimulated proliferation of astrocytes
1993 • 109 citations
Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas.
1989 • 108 citations
TGFβ1 and TGFβ2 are potential growth regulators for low‐grade and malignant gliomas in vitro: Evidence in support of an autocrine hypothesis
1991 • 107 citations
p53 Mutation, Expression, and DNA Ploidy in Evolving Gliomas: Evidence for Two Pathways of Progression
1994 • 104 citations
Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer.
1993 • 102 citations
Transforming growth factors type β1 and β2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-γ and tumor necrosis factor-α
1990 • 99 citations
Transforming growth factor-β1 regulates platelet-derived growth factor receptor β subunit in human liver fat-storing cells
1995 • 99 citations
The tumor suppressor protein p53
1995 • 98 citations
Differential effects of epidermal growth factor, transforming growth factor, and insulin on DNA and protein synthesis and morphology in serum-free cultures of AKR-2B cells.
1984 • 93 citations
Retinoblastoma gene deletions in human glioblastomas.
1991 • 89 citations
Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigm.
1992 • 89 citations
Mitogenic effect of transforming growth factor β1 on human fibroblasts involves the induction of platelet‐derived growth factor α receptors
1990 • 88 citations
Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.
1994 • 87 citations
Regulation of platelet-derived growth factor gene expression by transforming growth factor beta and phorbol ester in human leukemia cell lines.
1987 • 86 citations
Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-beta during tumor progression.
1993 • 86 citations
Overexpression of multiple oncogenes related to histological grade of astrocytic glioma
1992 • 85 citations
Effects of Transforming Growth Factor β1 on Astroglial Cells in Culture
1990 • 85 citations
Stimulatory role of transforming growth factors in multistage skin carcinogenesis: Possible explanation for the tumor‐inducing effect of wounding in initiated nmri mouse skin
1989 • 83 citations
Control of astrocytosis by interleukin-1 and transforming growth factor-β1 in human brain
1993 • 77 citations
Transforming growth factor β‐1 positively modulates the bioactivity of fibroblast growth factor on corneal endothelial cells
1989 • 73 citations
Effects of Transforming Growth Factor-β1 on Collagen Synthesis, Integrin Expression, Adhesion an Invasion of Glioma Cells
1995 • 73 citations
Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line.
1994 • 71 citations
Type I Receptors Specify Growth-Inhibitory and Transcriptional Responses to Transforming Growth Factor β and Activin
1994 • 70 citations
Induction of transforming growth factor beta 1 resistance by the E1A oncogene requires binding to a specific set of cellular proteins.
1991 • 69 citations
Transforming growth factor‐β1 inhibits the proliferation of rat astrocytes induced by serum and growth factors
1995 • 69 citations
Mutant p53 tumor suppressor gene causes resistance to transforming growth factor beta 1 in murine keratinocytes.
1993 • 68 citations
Transforming growth factor beta-treated normal fibroblasts eliminate transformed fibroblasts by induction of apoptosis.
1994 • 65 citations
Transforming growth factor β1 is a powerful modulator of platelet‐derived growth factor action in vascular smooth muscle cells
1992 • 64 citations
Progression of Colorectal Cancer Is Associated with Multiple Tumor Suppressor Gene Defects but Inhibition of Tumorigenicity Is Accomplished by Correction of Any Single Defect via Chromosome Transfer
1992 • 64 citations
A Novel Inhibitor of Cyclin-Cdk Activity Detected in Transforming Growth Factor β-Arrested Epithelial Cells
1994 • 60 citations
Transforming growth factor-beta inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I.
1992 • 59 citations
Transforming growth factor β1 treatment of AKR-2B cells is coupled through a pertussis-toxin-sensitive G-protein(s)
1989 • 57 citations
Transforming Growth Factor-β Induces Platelet-Derived Growth Factor (PDGF) Messenger RNA and PDGF Secretion while Inhibiting Growth in Normal Human Mammary Epithelial Cells
1990 • 50 citations
Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
1995 • 45 citations
Differential effects of transforming growth factor beta 1 on the growth of poorly and highly metastatic murine melanoma cells.
1990 • 44 citations
Enhanced jun Gene Expression Is an Early Genomic Response to Transforming Growth Factor β Stimulation
1989 • 41 citations
Transforming growth factor beta as a potent promoter in two-stage BALB/c 3T3 cell transformation.
1988 • 39 citations
TGFβ1 and TGFβ2 are potential growth regulators for medulloblastomas, primitive neuroectodermal tumors, and ependymomas: Evidence in support of an autocrine hypothesis
1994 • 38 citations
Molecular genetics of human glioma
1995 • 38 citations
Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
1989 • 37 citations
Retinoic acid induces secretion of latent transforming growth factor beta 1 and beta 2 in normal and human papillomavirus type 16-immortalized human keratinocytes.
1992 • 37 citations
Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells.
1992 • 36 citations
Control of the expression of c-sis mRNA in human glioblastoma cells by phorbol ester and transforming growth factor beta 1.
1989 • 34 citations
Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
1995 • 34 citations
Transforming growth factor-β in neural embryogenesis and neoplasia
1993 • 34 citations
Expression of platelet-derived growth factor and transforming growth factor and their correlation with cellular morphology in glial tumors
1991 • 34 citations
Transforming growth factor beta stimulates phosphoinositol metabolism and translocation of protein kinase C in cultured astrocytes
1988 • 32 citations
Modifications of cell cycle controlling nuclear proteins by transforming growth factor beta in the HaCaT keratinocyte cell line.
1992 • 32 citations
Distribution of transforming growth factor-β1 in human astrocytomas
1992 • 31 citations
The effects of type beta transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line
1988 • 31 citations
Transforming Growth Factor β1 Inhibition of p34cdc2 Phosphorylation and Histone H1 Kinase Activity Is Associated with G1/S-Phase Growth Arrest
1991 • 31 citations
Inactivation of the retinoblastoma gene does not lead to loss of TGF-beta receptors or response to TGF-beta in breast cancer cell lines.
1991 • 29 citations
Immunophenotypic differences between normal glia, astrocytomas and malignant gliomas: correlations with karyotype, natural history and survival
1989 • 28 citations
Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigm.
1992 • 26 citations
Interaction between p53 and TGF beta 1 in control of epithelial cell proliferation.
1995 • 26 citations
Reduction of TGF‐beta activity abrogates growth promoting tumor cell‐cell interactions in vivo
1991 • 26 citations
The properties of p53 proteins selected for the loss of suppression of transformation.
1994 • 23 citations
Tumor‐promoting activity of epstein‐barr‐ virus‐inducing factor transforming growth factor type beta (EIF/TGF‐β) is due to the induction of irreversible transformation
1991 • 20 citations
Interaction of acidic fibroblast growth factor and transforming growth factor-β in normal and transformed glia in vitro
1992 • 20 citations
RESISTANCE TO TGF-BETA-INDUCED ELIMINATION OF TRANSFORMED-CELLS IS REQUIRED DURING TUMOR PROGRESSION (REVIEW-HYPOTHESIS)
1995 • 18 citations
Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors.
1995 • 16 citations
Phenotypic alterations in fibroblasts and fibrosarcoma cells that overexpress latent transforming growth factor-beta 1.
1992 • 16 citations
TGF‐β induces an inhibitory effect of normal cells directed against transformed cells
1993 • 15 citations
Regulation of Platelet-Derived Growth Factor Gene Expression by Transforming Growth Factor β and Phorbol Ester in Human Leukemia Cell Lines
1987 • 14 citations
EFFECT OF TRANSFORMING GROWTH FACTOR‐β1 ON PLATELET‐DERIVED GROWTH FACTOR RECEPTOR BINDING AND GENE EXPRESSION IN VASCULAR SMOOTH MUSCLE CELLS FROM SHR AND WKY RATS
1994 • 13 citations
DNA index and S-phase in primary brain tumors
1994 • 10 citations
Suppressive Effect of Transforming Growth Factor-β on the Phosphorylation of Endogenous Substrates by Conventional and Novel Protein Kinase C in Primary Cultured Mouse Epidermal Cells
1993 • 9 citations
Direct transforming activity of TGF‐β on rat fibroblasts
1995 • 4 citations